Blog
RSS FeedPosted by Michael Wonder on 07 Jul 2020
ISPOR Working Group provides a first-ever cross-stakeholder consensus definition of “Patient Engagement in Research”
7 July 2020 - Value in Health announced today the publication of results of an ISPOR systematic review and analysis ...
Posted by Michael Wonder on 04 Jun 2020
Patients’ and health care professionals’ organisations updated on EMA’s response to COVID-19
4 June 2020 - EMA updated patients’ and healthcare professionals’ organisations about its COVID-19 activities. ...
Posted by Michael Wonder on 14 May 2020
Consumer comments needed for proposed new listings on the PBS
12 May 2020 - Lung Foundation Australia is seeking input from consumers to inform submissions on proposed listings of respiratory ...
Posted by Michael Wonder on 12 May 2020
Evaluation of the impact of patient involvement in health technology assessments: a scoping review
8 May 2020 - While involving patients in health technology assessment has become increasingly common and important around the world, little ...
Posted by Michael Wonder on 11 May 2020
Exploration of the visibility of patient input in final recommendation documentation for three health technology assessment bodies
7 May 2020 - Health technology assessment recommendations informed by patient concerns are seen to ensure democracy and legitimacy. ...
Posted by Michael Wonder on 16 Apr 2020
ICER Appoints Yvette Venable as Vice President of Patient Engagement
16 April 2020 - The Institute for Clinical and Economic Review has announced the appointment of Yvette Venable as the organisation’s ...
Posted by Michael Wonder on 12 Mar 2020
Defining the role of the public in Health Technology Assessment (HTA) and HTA-informed decision-making processes
10 March 2020 - The terminology used to describe community participation in health technology assessment is contested and frequently confusing. ...
Posted by Michael Wonder on 25 Feb 2020
TLV has decided on a policy for patient participation
21 February 2020 - TLV has taken another step in developing patient participation by developing a policy. ...
Posted by Michael Wonder on 29 Jan 2020
The FDA wants to know how Instagram influencers sway patient views on medicines
28 January 2020 - In 2015, Kim Kardashian promoted a morning-sickness pill to her millions of followers on social media, ...
Posted by Michael Wonder on 17 Jan 2020
Use of patient preference studies in HTA decision making: a NICE perspective
16 January 2020 - Patient preference studies could provide valuable insights to a National Institute for Health and Care Excellence committee ...
Posted by Michael Wonder on 02 Dec 2019
Engaging patients in medicines regulation: a tale of two agencies
2 December 2019 - The EMA and the US FDA have committed to engaging patients in their regulatory processes to promote ...
Posted by Michael Wonder on 10 Nov 2019
Patient perspective is vital to FDA's work
7 November 2019 - As an oncologist, I was eager to come work at the U.S. FDA, where I knew ...
Posted by Michael Wonder on 02 Oct 2019
Advancing patient engagement
2 October 2019 - It’s widely accepted that seeking patient input into their health and care improves outcomes for them and ...
Posted by Michael Wonder on 23 Sep 2019
Statement on FDA efforts to encourage patient engagement in medical device clinical investigations
23 September 2019 - At the U.S. FDA we are committed to keeping patients, their families and caregivers at the center ...
Posted by Michael Wonder on 06 Aug 2019
A watchdog group sets aside emotions to assess drugs’ value. Patients say their lives are more than a number.
2 August 2019 - Health economists walk a precarious tightrope: their analyses are quantitative and, presumably, emotion-free. But health care ...